Rizatriptan Benzoate
Product Images NDC 50090-4619

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 50090-4619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure01 (Fig01)

A line graph comparing the estimated probability of response over 2 hours post-dose for placebo, rizatriptan benzoate 5 mg, and rizatriptan benzoate 10 mg. The x-axis represents hours post-dose, and the y-axis represents the estimated probability of response percentage. The graph shows higher response rates with increasing doses of rizatriptan benzoate compared to placebo.*

FDA Label Image

Figure02 (Fig02)

A line graph comparing estimated probability of headache relief over 24 hours post-dose among placebo, rizatriptan benzoate 5 mg, and rizatriptan benzoate 10 mg. The y-axes show percentage probability of relief; the x-axis shows hours after dosing. Rizatriptan benzoate doses show higher relief rates than placebo over time.*

FDA Label Image

Figure5

Line graph comparing the percent response over time (in hours) post stage 2 dose between Rizatriptan Benzoate OD Tablets and a placebo. The x-axis represents hours post dose (0.5, 1.0, 1.5, 2.0), and the y-axis shows percent with 95% confidence intervals. Rizatriptan benzoate shows a higher percent response compared to placebo over time.*

FDA Label Image

Label Image (Lbl500904619)

rizatriptan benzoate 10 mg tablet label from A-S Medication Solutions, showing product number 6404-0 and NDC 50090-4619-0. The label indicates each tablet contains 14.53 mg rizatriptan benzoate equivalent to 10 mg rizatriptan, with storage instructions and package quantity details (18 blister packs of 3 x 6 tablets each).*

FDA Label Image

Structure (Structure)

Chemical structure of rizatriptan benzoate showing its molecular composition and arrangement including an indole moiety, a dimethylamine group, and a benzoate component characterized by a carboxyl group attached to a benzene ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.